Good news! The FDA has announced the Over-the-Counter (OTC) Drug Monograph Facility Fee for Fiscal Year 2026, with fees nearly halved!
The FDA has officially announced the fee standards for Over-the-Counter (OTC) Drug Monograph facilities for Fiscal Year (FY) 2026. Compared to the previous year, the fees for 2026 have been significantly reduced by nearly 50%%, with the Monthly Dispensing Fee (MDF) facility fee dropping to $19,188$. This favorable news is mainly attributed to the offset of surplus funds and an increase in the number of registered facilities. This article provides a detailed comparison of the fee differences between FY 2025 and FY 2026 and lists the key payment deadlines to help businesses comply and reduce their burden.










